GB Sciences Common Stock

GB Sciences (GBLX) currently reports a common stock of $41K as of December 2024. That compares with $41K in the prior-year period — up 0.2% year over year. Use the charts on this page to explore GB Sciences's common stock history and peer comparisons.

GB Sciences's common stock increased from $41K to $41K — a 0.2% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GB Sciences reported $41K in common stock as of December 2024. That compares with $41K in the prior-year period — up 0.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $41K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GB Sciences, and consider following GBLX for alerts when major investors trade the stock.

GB Sciences is classified in the Healthcare sector. On common stock, it currently shows $41K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GBLX with unrelated industries.